Virtu Financial’s TRACON Pharmaceuticals TCON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,418
Closed -$8K – 2081
2023
Q2
$8K Buy
+1,418
New +$25.9K ﹤0.01% 1375
2023
Q1
– Sell
-2,264
Closed -$67K – 2283
2022
Q4
$67K Buy
+2,264
New +$68.5K 0.01% 1031
2021
Q4
– Sell
-747
Closed -$58K – 2290
2021
Q3
$58K Buy
+747
New +$63.2K 0.01% 1249
2020
Q4
– Sell
-3,059
Closed -$316K – 1885
2020
Q3
$316K Buy
3,059
+1,126
+58% +$60.3K 0.05% 417
2020
Q2
$76K Buy
+1,933
New +$76.5K 0.01% 941
2019
Q3
– Sell
-167
Closed -$23K – 1929
2019
Q2
$23K Buy
+167
New +$26.4K ﹤0.01% 1331
2019
Q1
– Sell
-91
Closed -$11K – 1965
2018
Q4
$11K Sell
91
-40
-31% -$10.9K ﹤0.01% 1434
2018
Q3
$54K Buy
131
+38
+41% +$17.6K ﹤0.01% 1292
2018
Q2
$50K Sell
93
-115
-55% -$61.2K ﹤0.01% 1752
2018
Q1
$96K Buy
208
+153
+278% +$83.4K 0.01% 1589
2017
Q4
$37K Sell
55
-63
-53% -$38K ﹤0.01% 2126
2017
Q3
$75K Buy
+118
New +$61.5K ﹤0.01% 2144

Other funds holding TCON

Virtu Financial's TCON Position: Q3 2023 in Review

Virtu Financial sold out of TRACON Pharmaceuticals (TCON) in Q3 2023, closing a stake of 1,418 shares — an estimated $8K sold.

Virtu Financial first reported a position in TCON in Q3 2017 and held it in 12 quarters. The position peaked at $316K in Q3 2020. 21 funds tracked by Wall St. Rank hold TCON as of Q3 2023.

  • Virtu Financial reported no remaining TRACON Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 1,418 TRACON Pharmaceuticals shares in Q3 2023, an estimated $8K.
  • Virtu Financial first reported a position in TRACON Pharmaceuticals in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's TRACON Pharmaceuticals position peaked at $316K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.